Steven Cohen's BSX Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 1.63 M shares of Boston Scientific Corporation (BSX) worth $159.24 M, representing 0.27% of the portfolio. First purchased in 2014-Q3, this long-term strategic position has been held for 45 quarters.
Based on 13F filings since 2013, Steven Cohen has maintained a long-term strategic position in BSX, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2023, adding 2.93 M shares. Largest reduction occurred in Q1 2015, reducing 2.94 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Boston Scientific Corporation (BSX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Boston Scientific Corporation (BSX) Trades by Steven Cohen
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2014 | +2.52 M | New Buy | 2.52 M | $11.81 |
| Q4 2014 | +2.12 M | Add 84.14% | 4.65 M | $13.25 |
| Q1 2015 | -2.94 M | Reduce 63.29% | 1.71 M | $17.75 |
| Q2 2015 | +1.08 M | Add 63.60% | 2.79 M | $17.70 |
| Q3 2015 | -152,100 | Reduce 5.45% | 2.64 M | $16.41 |
| Q4 2015 | -1.95 M | Reduce 73.84% | 690,300 | $18.44 |
| Q1 2016 | +1.98 M | Add 286.15% | 2.67 M | $18.81 |
| Q2 2016 | -749,618 | Reduce 28.12% | 1.92 M | $23.37 |
| Q3 2016 | -293,382 | Reduce 15.31% | 1.62 M | $23.80 |
| Q4 2016 | -1.26 M | Reduce 77.91% | 358,400 | $21.63 |
| Q1 2017 | -358,400 | Sold Out | 358,400 | $0.00 |
| Q2 2017 | +1.05 M | New Buy | 1.05 M | $27.72 |
| Q3 2017 | -922,000 | Reduce 88.02% | 125,500 | $29.17 |
| Q4 2017 | -125,500 | Sold Out | 125,500 | $0.00 |
| Q1 2018 | +1.1 M | New Buy | 1.1 M | $27.32 |
| Q2 2018 | +370,800 | Add 33.76% | 1.47 M | $32.70 |
| Q3 2018 | +1.59 M | Add 108.26% | 3.06 M | $38.50 |
| Q4 2018 | -2.91 M | Reduce 95.17% | 147,712 | $35.34 |
| Q1 2019 | -137,040 | Reduce 92.78% | 10,672 | $38.42 |
| Q2 2019 | +38,135 | Add 357.34% | 48,807 | $42.99 |
| Q3 2019 | -48,807 | Sold Out | 48,807 | $0.00 |
| Q4 2019 | +636,554 | New Buy | 636,554 | $45.22 |
| Q1 2020 | -636,554 | Sold Out | 636,554 | $0.00 |
| Q3 2020 | +47,860 | New Buy | 47,860 | $38.22 |
| Q4 2020 | +47,140 | Add 98.50% | 95,000 | $35.95 |
| Q1 2021 | -95,000 | Sold Out | 95,000 | $0.00 |
| Q3 2021 | +1.09 M | New Buy | 1.09 M | $43.39 |
| Q4 2021 | +817,400 | Add 75.30% | 1.9 M | $42.48 |
| Q1 2022 | +817,822 | Add 42.98% | 2.72 M | $44.29 |
| Q2 2022 | +22,144 | Add 0.81% | 2.74 M | $37.27 |
| Q3 2022 | +182,829 | Add 6.67% | 2.93 M | $38.73 |
| Q4 2022 | -2.73 M | Reduce 93.24% | 197,869 | $46.27 |
| Q1 2023 | +1.58 M | Add 800.44% | 1.78 M | $50.03 |
| Q2 2023 | +1.71 M | Add 95.92% | 3.49 M | $54.09 |
| Q3 2023 | +2.93 M | Add 83.97% | 6.42 M | $52.80 |
| Q4 2023 | -1.71 M | Reduce 26.64% | 4.71 M | $57.81 |
| Q1 2024 | -2.34 M | Reduce 49.77% | 2.37 M | $68.49 |
| Q2 2024 | +758,833 | Add 32.07% | 3.13 M | $77.01 |
| Q3 2024 | +256,797 | Add 8.22% | 3.38 M | $83.80 |
| Q4 2024 | -1.14 M | Reduce 33.59% | 2.25 M | $89.32 |
| Q1 2025 | -365,264 | Reduce 16.26% | 1.88 M | $100.88 |
| Q2 2025 | +580,128 | Add 30.85% | 2.46 M | $107.41 |
| Q3 2025 | -829,610 | Reduce 33.71% | 1.63 M | $97.63 |
Steven Cohen's Boston Scientific Corporation Investment FAQs
Steven Cohen first purchased Boston Scientific Corporation (BSX) in Q3 2014, acquiring 2,523,500 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Boston Scientific Corporation (BSX) for 45 quarters since Q3 2014. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen's largest addition to Boston Scientific Corporation (BSX) was in Q3 2023, adding 6,421,754 shares worth $339.07 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 1,631,053 shares of Boston Scientific Corporation (BSX), valued at approximately $159.24 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Boston Scientific Corporation (BSX) represents approximately 0.27% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen's peak holding in Boston Scientific Corporation (BSX) was 6,421,754 shares, as reported at the end of Q3 2023. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.